HUMA · Humacyte, Inc. · Debt
$0.44
+0.02 (+5.40%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company will not have sufficient liquidity to fund its operations beyond one year from the issuance of these condensed consolidated financial statements if the Company is unable to generate sufficient cash flows from commercial sales on a timely basis and/or obtain additional capital. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$120.95M
Shares
277.80M
Volume · Oct 23
2.61M
Avg daily vol (3M)
6.43M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2026-06-30 | USD 1,518,000 | 10-Q filed 2026-08-12 |
| Long-term debt, including current maturities | 2026-06-30 | USD 36,324,000 | 10-Q filed 2026-08-12 |
| Noncurrent finance lease liabilities | 2026-06-30 | USD 28,338,000 | 10-Q filed 2026-08-12 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1818382
CUSIP
44486Q103
13F (30d)
24 filings
24 filers
Visit website
Investor relations